| Appearance and Shape (20°C) | Solid | 
|---|---|
| CAS RN | 297-76-7 | 
| MDL number | MFCD00083326 | 
| Molecular weight | 384.52 | 
| Molecular Formula | C24H32O4 | 
| Product code | ICTE1315 | 
| Purity/Analytical Methods | >96.0%(HPLC) | 
| Reaxys-RN | 3040143 | 
| Appearance | White to Almost white powder to crystal | 
|---|
| Pictograms | 
                                                                                             
                                                                                     | 
                                    
|---|---|
| Hazard statement | H361 : Suspected of damaging fertility or the unborn child H351 : Suspected of causing cancer. | 
| Precautionary Statements | P501 : Dispose of contents/ container to an approved waste disposal plant P202 : Do not handle until all safety precautions have been read and understood P201 : Obtain special instructions before use P280 : Wear protective gloves/ protective clothing/ eye protection/ face protection P308 + P313 : IF exposed or concerned: Get medical advice/ attention P405 : Store locked up. | 
| Signal word | Warning | 
| RTECS# | RC8963000 | 
|---|
Life Science Biochemicals and Reagents Pharmaceutical Ingredients (for Research and Experimental Use) Anti-osteoporosis Ingredients (for Research and Experimental Use) Estrogens [Anti-osteoporosis Ingredients] Cell Biology Cell Signaling and Neuroscience Cytokines, Growth Factors and Hormones Steroid Hormones Estrogen Hormones [Cytokines, Growth Factors and Hormones] Pharmaceutical Development and Drug Discovery Research Pharmaceutical Ingredients (for Research and Experimental Use) Anti-osteoporosis Ingredients (for Research and Experimental Use) Estrogens [Anti-osteoporosis Ingredients]